Phenobarbital-induced coagulation defects in cats.
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D000831:Animals, Newborn; D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D002415:Cats; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005166:Factor V Deficiency / Q000139:chemically induced; D005167:Factor VII / Q000096:biosynthesis; D005168:Factor VII Deficiency / Q000139:chemically induced; D005260:Female; D005492:Folic Acid / Q000097:blood; D006467:Hemophilia A / Q000139:chemically induced; D007020:Hypoprothrombinemias / Q000139:chemically induced; D008099:Liver / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D010634:Phenobarbital / Q000008:administration & dosage / Q000494:pharmacology*; D010672:Phenytoin / Q000494:pharmacology; D011247:Pregnancy; D011324:Primidone / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D014812:Vitamin K / Q000494:pharmacology
D014812:Vitamin K; D011324:Primidone; D010672:Phenytoin; D005167:Factor VII; D005492:Folic Acid; D000410:Alanine Transaminase; D010634:Phenobarbital